AR031250A1 - Composiciones y metodos para la terapia y el diagnostico del cancer de pulmon - Google Patents
Composiciones y metodos para la terapia y el diagnostico del cancer de pulmonInfo
- Publication number
- AR031250A1 AR031250A1 ARP010103274A ARP010103274A AR031250A1 AR 031250 A1 AR031250 A1 AR 031250A1 AR P010103274 A ARP010103274 A AR P010103274A AR P010103274 A ARP010103274 A AR P010103274A AR 031250 A1 AR031250 A1 AR 031250A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- diagnosis
- cancer
- polypeptides
- therapy
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000003745 diagnosis Methods 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 208000020816 lung neoplasm Diseases 0.000 abstract 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 201000005202 lung cancer Diseases 0.000 abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000037841 lung tumor Diseases 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/614,124 US6630574B1 (en) | 1999-06-30 | 2000-07-11 | Compositions and methods for the therapy and diagnosis of lung cancer |
US09/651,563 US6914132B1 (en) | 1999-06-30 | 2000-08-29 | Compositions and methods for the therapy and diagnosis of lung cancer |
US09/658,824 US6746846B1 (en) | 1999-06-30 | 2000-09-08 | Methods for diagnosing lung cancer |
US09/671,325 US6667154B1 (en) | 1999-06-30 | 2000-09-26 | Compositions and methods for the therapy and diagnosis of lung cancer |
US67741900A | 2000-10-06 | 2000-10-06 | |
US09/702,705 US6504010B1 (en) | 1999-06-30 | 2000-10-30 | Compositions and methods for the therapy and diagnosis of lung cancer |
US09/736,457 US6509448B2 (en) | 1999-06-30 | 2000-12-13 | Compositions and methods for the therapy and diagnosis of lung cancer |
US09/849,626 US20020197669A1 (en) | 2000-12-13 | 2001-05-03 | Compositions and methods for the therapy and diagnosis of lung cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AR031250A1 true AR031250A1 (es) | 2003-09-17 |
Family
ID=27575493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010103274A AR031250A1 (es) | 2000-07-11 | 2001-07-10 | Composiciones y metodos para la terapia y el diagnostico del cancer de pulmon |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1343886A2 (fr) |
JP (1) | JP2004512824A (fr) |
AR (1) | AR031250A1 (fr) |
AU (1) | AU2002218770A1 (fr) |
CA (1) | CA2415544A1 (fr) |
WO (1) | WO2002004514A2 (fr) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030170255A1 (en) * | 1999-06-30 | 2003-09-11 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US20030211510A1 (en) | 1999-06-30 | 2003-11-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6893818B1 (en) | 1999-10-28 | 2005-05-17 | Agensys, Inc. | Gene upregulated in cancers of the prostate |
JP2004522404A (ja) * | 1999-12-01 | 2004-07-29 | ジェネンテック・インコーポレーテッド | 分泌及び膜貫通ポリペプチドとそれをコードしている核酸 |
US20030166300A1 (en) * | 2000-08-30 | 2003-09-04 | Tang Y. Tom | Growth-related inflammatory and immune response protein |
ZA200204907B (en) * | 2001-06-26 | 2003-03-03 | Univ Nat Taiwan | Collapsin Response Mediator Protein-1. |
EP1543018A4 (fr) * | 2002-08-14 | 2006-10-25 | Lg Life Sciences Ltd | Familles de genes associees au cancer du foie |
JP2006519582A (ja) * | 2002-09-26 | 2006-08-31 | ジェネンテック・インコーポレーテッド | 乾癬の治療のための新規組成物と方法 |
TW200413725A (en) * | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
US7449291B1 (en) | 2003-01-13 | 2008-11-11 | University Of Washington | Methods for identifying subjects susceptible to Charcot-Marie-Tooth neuropathy type 1C |
WO2004070058A1 (fr) * | 2003-02-03 | 2004-08-19 | Bayer Healthcare Ag | Methodes et compositions permettant de prevoir, diagnostiquer, pronostiquer, prevenir et traiter des broncho-pneumopathies chroniques obstructives |
WO2004084804A2 (fr) * | 2003-03-24 | 2004-10-07 | Corixa Corporation | Methodes, compositions et trousses pour la detection et pour la surveillance d'un cancer du poumon |
ATE528397T1 (de) | 2003-08-08 | 2011-10-15 | Perseus Proteomics Inc | Bei krebs überexprimiertes gen |
JP4579246B2 (ja) | 2003-09-24 | 2010-11-10 | オンコセラピー・サイエンス株式会社 | 乳癌を診断する方法 |
JP4428995B2 (ja) | 2003-12-03 | 2010-03-10 | 関東化学株式会社 | 金属膜のエッチング液組成物 |
JP2008507261A (ja) * | 2004-01-27 | 2008-03-13 | コンピュゲン ユーエスエイ,インク. | 肺癌診断のための新規のヌクレオチド配列およびアミノ酸配列、ならびにそのアッセイおよび使用方法 |
US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
AU2005227598B2 (en) | 2004-03-31 | 2011-01-20 | Hiroyuki Aburatani | Cancer diagnosis and treatment using anti-ROBO1 antibody |
US8940488B2 (en) | 2004-03-31 | 2015-01-27 | Hiroyuki Aburatani | Cancer diagnosis and treatment of cancer using anti-robo 1 antibody |
EP1915622A2 (fr) * | 2005-07-29 | 2008-04-30 | Oncotherapy Science, Inc. | Criblage et methode therapeutique anti-nsclc ciblant le complexe cda1-kntc2 |
US20110038849A1 (en) * | 2006-12-21 | 2011-02-17 | Intradigm Corporation | Inhibitory polynucleotide compositions and methods for treating cancer |
JP5117765B2 (ja) | 2007-05-28 | 2013-01-16 | 国立大学法人 東京大学 | 抗robo1抗体を含むpet用腫瘍診断剤 |
BRPI0815578B8 (pt) * | 2007-08-20 | 2021-05-25 | Oncotherapy Science Inc | peptídeos, agentes farmacêuticos compreendendo os mesmos, métodos in vitro para induzir uma célula apresentadora de antígeno, usos dos referidos peptídeos, e vacina |
TWI526219B (zh) | 2008-06-19 | 2016-03-21 | 腫瘤療法 科學股份有限公司 | Cdca1抗原決定位胜肽及含此胜肽的疫苗 |
WO2010134601A1 (fr) * | 2009-05-22 | 2010-11-25 | 国立大学法人岡山大学 | Peptide induisant une réponse immunitaire spécifique contre xage-1b et son utilisation |
JP6255593B2 (ja) | 2012-07-10 | 2018-01-10 | オンコセラピー・サイエンス株式会社 | Th1細胞のCDCA1エピトープペプチドおよびこれを含有するワクチン |
CN114102955B (zh) * | 2020-08-31 | 2024-05-07 | 天津科技大学 | 一种采用常温发泡技术制备发泡聚乳酸的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10139800A (ja) * | 1996-11-15 | 1998-05-26 | Santen Pharmaceut Co Ltd | シェーグレン症候群治療剤 |
ID27813A (id) * | 1998-01-28 | 2001-04-26 | Corixa Corp | Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya |
WO2000055375A1 (fr) * | 1999-03-17 | 2000-09-21 | Alphagene, Inc. | Proteines secretees et polynucleotides les codant |
WO2001000828A2 (fr) * | 1999-06-30 | 2001-01-04 | Corixa Corporation | Compositions et techniques de therapie et de diagnostic du cancer du poumon |
-
2001
- 2001-07-10 AU AU2002218770A patent/AU2002218770A1/en not_active Abandoned
- 2001-07-10 AR ARP010103274A patent/AR031250A1/es unknown
- 2001-07-10 WO PCT/US2001/022058 patent/WO2002004514A2/fr active Application Filing
- 2001-07-10 EP EP01984164A patent/EP1343886A2/fr not_active Withdrawn
- 2001-07-10 JP JP2002509377A patent/JP2004512824A/ja active Pending
- 2001-07-10 CA CA002415544A patent/CA2415544A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1343886A2 (fr) | 2003-09-17 |
WO2002004514A3 (fr) | 2003-06-19 |
JP2004512824A (ja) | 2004-04-30 |
AU2002218770A1 (en) | 2002-01-21 |
WO2002004514A2 (fr) | 2002-01-17 |
WO2002004514A8 (fr) | 2002-12-27 |
CA2415544A1 (fr) | 2002-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR031250A1 (es) | Composiciones y metodos para la terapia y el diagnostico del cancer de pulmon | |
AR032743A1 (es) | Composiciones y metodos para la terapia y el diagnostico de cancer de pulmon | |
MXPA03001634A (es) | Polipeptido tumoral cripto. | |
WO2001072295A3 (fr) | Compositions et methodes pouvant traiter ou diagnostiquer le cancer du poumon | |
WO2004113571A3 (fr) | Genes specifiques de la prostate et leur utilisation comme cibles dans le traitement et le diagnostic du cancer de la prostate | |
BR0009537A (pt) | Composições para tratamento e diagnóstico de câncer de mama e métodos para seu uso | |
NO20053999D0 (no) | Survivin-avledede peptider og bruken av dem | |
WO2001092581A3 (fr) | Compositions et methodes permettant le traitement et le diagnostic du cancer de l'ovaire | |
WO2002092001A3 (fr) | Compositions et methodes de traitement et de diagnostic du cancer du poumon | |
BR9808509A (pt) | Composições e métodos para o tratamento e diagnóstico do câncer de mama | |
WO2006031363A3 (fr) | Compositions et procedes pour la therapie et le diagnostic du cancer du poumon | |
HRPK20041072B3 (en) | Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer | |
WO2003037267A3 (fr) | Compositions et methodes de traitement et de diagnostic du cancer des poumons | |
WO2001077168A3 (fr) | Compositions et procedes permettant de traiter et de diagnostiquer le cancer du poumon | |
MXPA02011563A (es) | Composicionesy metodos para la terapia y diagnostico de cancer de seno. | |
WO2003013431A3 (fr) | Compositions et techniques de therapie et de diagnostic du cancer du sein | |
WO2002039885A3 (fr) | Compositions et methodes destinees a la therapie et au diagnostic du cancer de l'ovaire | |
WO2005051990A3 (fr) | Compositions et procedes pour le traitement et le diagnostic du cancer du sein | |
AR029547A1 (es) | Composiciones y metodos para la terapia y el diagnostico de cancer de pulmon | |
WO2002000174A3 (fr) | Compositions et methodes pour le traitement et le diagnostic du cancer du poumon | |
WO2003086175A8 (fr) | Compositions et procedes destines au traitement et au diagnostic du cancer du poumon | |
DE60139150D1 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs | |
WO2002062203A3 (fr) | Compositions et methodes de therapie et de diagnostic du cancer du sein | |
BRPI0409321A (pt) | antìgeno hìbrido, competição e método para induzir uma resposta imune para um agente infeccioso ou antìgeno de tumor, método para tratar uma doença infecciosa ou cáncer, e, peptìdeo | |
WO2001098339A3 (fr) | Compositions et procedes de traitement et de diagnostic du cancer du sein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |